Biotricity, Inc. (BTCY)
OTCMKTS · Delayed Price · Currency is USD
0.5400
-0.0300 (-5.26%)
Aug 29, 2025, 3:34 PM EDT
Biotricity Market Cap
Biotricity has a market cap or net worth of $14.43 million as of August 29, 2025. Its market cap has increased by 48.15% in one year.
Market Cap
14.43M
Enterprise Value
43.00M
Revenue
14.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.54
Market Cap Chart
Since February 18, 2016, Biotricity's market cap has decreased from 187.13M to 14.43M, a decrease of -92.29%. That is a compound annual growth rate of -23.57%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 29, 2025 | 14.43M | 102.79% |
Dec 31, 2024 | 7.12M | -31.33% |
Dec 29, 2023 | 10.37M | -61.10% |
Dec 30, 2022 | 26.65M | -88.14% |
Dec 31, 2021 | 224.72M | 464.80% |
Dec 31, 2020 | 39.79M | 13.76% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Feb 18, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Nika Pharmaceuticals | 972.42M |
Veradigm | 832.17M |
Elite Pharmaceuticals | 734.61M |
Tian'an Technology Group | 682.77M |
Glass House Brands | 655.63M |
Northwest Biotherapeutics | 448.50M |
CytoDyn | 376.00M |
American Oncology Network | 343.87M |